Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Bloomberg Markets

Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui

Bristol-Myers Inks Up to $15 Billion Licensing Deal With Hengrui
ShareXFacebook

Bristol-Myers Squibb Co. inked a collaboration and licensing deal with Jiangsu Hengrui Pharmaceuticals Co. that could be valued at as much as $15.2 billion, as the US drugmaker seeks to leverage China’s efficiency in early development.

B

Source

Bloomberg Markets

Read full article at Bloomberg Markets

Opens original article in a new tab

Advertisement

Related Economy Stories

Horizons Middle East & Africa 5/12/2026
Bloomberg Markets

Horizons Middle East & Africa 5/12/2026

Horizons Middle East & Africa is your daily spotlight on one of the world's fastest-growing regions. Live from Dubai, we bring you the latest global markets and analysis, plus news-making interviews, with a special focus on MEA. All that and more, as you head to the office in the Gulf, pause for lunch in Hong Kong, or start your day in London or Johannesburg. (Source: Bloomberg)

Read more →
Advertisement